Tài chính

Quick Read LLY's FDA-cleared oral GLP-1 Foundayo drove 55.5% Q1 revenue growth, supporting a BUY rating with a $1,365 price target. Novo Nordisk's sales fell 4% with a 50% Wegovy price cut looming, while Merck posted just 5% growth, underscoring LLY's competitive edge.

Quick Read HPE surged 90% since Elliott's March 31 filing and still screens as a Buy; TFPM also rates Buy with 32% upside. Phillips 66 has blown past its $198 analyst target and all three modeled scenarios now project negative to flat one-year returns. Southwest swung from a $149

NOT FOR DISTRIBUTION IN THE UNITED STATES CALGARY, Alberta, July 24, 2026 (GLOBE NEWSWIRE) — Helium Evolution Incorporated (TSXV:HEVI, OTCQB:HEEVF) (“HEVI” or the “Company“), a Canadian-based helium exploration company holding the largest helium land position in North America amo

Robert McLister: Big Banks are faster to hike than to cut, and are still waiting to see if the latest yield spike will last

Error in retrieving data

Error in retrieving data

Error in retrieving data